Connect with us

Business

Why CSL shares could be dirt cheap in 2025

Published

on

Image source: Getty Images

Now could be the time to pounce on CSL Ltd (ASX: CSL) shares.

That’s the view of analysts at Goldman Sachs, which have just initiated coverage on the company.

CSL is a global biotechnology company with a world-class portfolio of therapies. This includes therapies that…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending